<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03767166</url>
  </required_header>
  <id_info>
    <org_study_id>2275</org_study_id>
    <nct_id>NCT03767166</nct_id>
  </id_info>
  <brief_title>The Archimedes Biodegradable Biliary and Pancreatic Stents</brief_title>
  <acronym>ARCHIMEDES</acronym>
  <official_title>A Prospective, Single Arm Study to Evaluate the Feasibility of the Archimedes Biodegradable Biliary and Pancreatic Stents Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, phase II, single-centre, non-randomised, single-arm study, enrolling&#xD;
      patients with benign and malignant bilio-pancreatic diseases with an indication to biliary or&#xD;
      pancreatic plastic stent positioning during ERCP.&#xD;
&#xD;
      On procedure day, the study team will confirm that the patient meets all the inclusion&#xD;
      criteria and none of the exclusion criteria.&#xD;
&#xD;
      The patient will undergo the ABS insertion and monitored and follow-up accordingly to&#xD;
      biodegration variant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biodegradation time</measure>
    <time_frame>24 Months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Pancreatic Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biodegradable biliary and pancreatic stents placement</intervention_name>
    <description>Biodegradable biliary and pancreatic stents placement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with benign and malignant bilio-pancreatic diseases with an indication to biliary&#xD;
        or pancreatic plastic stent positioning during ERCP.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with an indication to position one ore more biliary plastic stents during&#xD;
             ERCP&#xD;
&#xD;
          -  Patients with an indication to position a pancreatic plastic stent during ERCP&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 y&#xD;
&#xD;
          -  Life expectancy &lt; 1 m,&#xD;
&#xD;
          -  Inability to pass a guidewire through stricture&#xD;
&#xD;
          -  Contra-indication for endoscopy or interventional radiology&#xD;
&#xD;
          -  Presence of partial gastric resection&#xD;
&#xD;
          -  Unsigned informing consent form, ICF&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Pseudo Klatskin tumors (metastases in the liver hilum) and gallbladder carcinoma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Endoscopy Unit, Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <state>Milano</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 20, 2018</study_first_submitted>
  <study_first_submitted_qc>December 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2018</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

